Updates

CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES

Oct 28, 2021

Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the Read More

ICYMI: NEW STUDY FINDS BIG PHARMA SPENT MORE ON SALES AND MARKETING THAN R&D DURING PANDEMIC

Oct 27, 2021

AHIP Study Finds Top Drug Companies’ Sales and Marketing Budgets Swamp Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE

Oct 22, 2021

First Round of Q3 Earnings Reports Show Big Pharma Companies Raking in Big Read More

WHAT THEY ARE SAYING: AMERICANS NATIONWIDE CALL ON CONGRESS TO LOWER RX PRICES NOW

Oct 21, 2021

Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented Read More

CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP

Oct 20, 2021

U.S. Food & Drug Administration Approval of Cyltezo Marks Second Read More

ICYMI: AARP POLL FINDS OVERWHELMING MAJORITY OF ARIZONA VOTERS WANT SOLUTIONS TO LOWER RX PRICES

Oct 15, 2021

New Survey Contributes to Unprecedented Momentum for Congress to Hold Big Read More

ICYMI: VOTERS EXPECT CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE AND LOWER DRUG PRICES

Sep 30, 2021

Voters Expect Congress to Hold Big Pharma Accountable and Lower Drug Prices Read More

CSRXP ENCOURAGES HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Sep 29, 2021

Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive Read More

ICYMI: BIG PHARMA HIKED PRICES ON SPECIALTY DRUGS BY MORE THAN THREE TIMES THE RATE OF INFLATION

Sep 28, 2021

AARP Report Finds Pharmaceutical Companies’ Price Increases Outpacing Read More

CSRXP POLL: MASSIVE MAJORITIES OF AMERICAN VOTERS SUPPORT SOLUTIONS TO LOWER DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE

Sep 14, 2021

Americans Blame Big Pharma for Out-of-Control Drug Prices, Reject Bogus Read More

CSRXP: HOUSE MARKUPS ADD TO UNPRECEDENTED MOMENTUM TO HOLD BIG PHARMA ACCOUNTABLE

Sep 14, 2021

Committee Leaders Put Forward Solutions to Lower Prescription Drug Prices for Read More

CSRXP APPLAUDS RELEASE OF HHS PLAN TO LOWER PRESCRIPTION DRUG PRICES AND HOLD BIG PHARMA ACCOUNTABLE

Sep 9, 2021

Administration Proposal Would Increase Competition, Transparency and Value — Read More